| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.8009226 |
| P698 | PubMed publication ID | 8009226 |
| P50 | author | Kazimiera Waśniowska | Q67353624 |
| Chetan Eknath Chitnis | Q5094149 | ||
| P2093 | author name string | L H Miller | |
| B K Sim | |||
| T J Hadley | |||
| P433 | issue | 5167 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | erythrocyte invasion | Q122665572 |
| erythrocyte binding antigen-175 | Q56564080 | ||
| erythrocyte binding antigen-175 | Q56721792 | ||
| Plasmodium falciparum | Q311383 | ||
| P1104 | number of pages | 4 | |
| P304 | page(s) | 1941-1944 | |
| P577 | publication date | 1994-06-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum | |
| P478 | volume | 264 |
| Q30043024 | A Plasmodium falciparum homologue of Plasmodium vivax reticulocyte binding protein (PvRBP1) defines a trypsin-resistant erythrocyte invasion pathway |
| Q47841933 | A Plasmodium falciparum novel gene encoding a coronin-like protein which associates with actin filaments |
| Q27976477 | A Presenilin-like protease associated with Plasmodium falciparum micronemes is involved in erythrocyte invasion |
| Q36064827 | A Stem Cell Strategy Identifies Glycophorin C as a Major Erythrocyte Receptor for the Rodent Malaria Parasite Plasmodium berghei. |
| Q33195225 | A co-ligand complex anchors Plasmodium falciparum merozoites to the erythrocyte invasion receptor band 3. |
| Q39532857 | A conserved region in the EBL proteins is implicated in microneme targeting of the malaria parasite Plasmodium falciparum |
| Q30045314 | A family of chimeric erythrocyte binding proteins of malaria parasites |
| Q60310868 | A forward genetic screen reveals a primary role for Plasmodium falciparum Reticulocyte Binding Protein Homologue 2a and 2b in determining alternative erythrocyte invasion pathways |
| Q34991300 | A library of functional recombinant cell-surface and secreted P. falciparum merozoite proteins |
| Q35227478 | A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein |
| Q48015377 | A mathematical model for a new mechanism of phenotypic variation in malaria |
| Q36063959 | A new release on life: emerging concepts in proteolysis and parasite invasion |
| Q43868711 | A novel Plasmodium falciparum erythrocyte binding protein-2 (EBP2/BAEBL) involved in erythrocyte receptor binding |
| Q27230077 | A novel Plasmodium falciparum rhoptry associated adhesin mediates erythrocyte invasion through the sialic-acid dependent pathway |
| Q28608223 | A novel locus of resistance to severe malaria in a region of ancient balancing selection. |
| Q24600538 | A plethora of Plasmodium species in wild apes: a source of human infection? |
| Q34004960 | A protective glycosylphosphatidylinositol-anchored membrane protein of Plasmodium yoelii trophozoites and merozoites contains two epidermal growth factor-like domains |
| Q37632441 | A quantitative assay for binding and inhibition of Plasmodium falciparum Erythrocyte Binding Antigen 175 reveals high affinity binding depends on both DBL domains |
| Q39516438 | A recombinant baculovirus-expressed Plasmodium falciparum receptor-binding domain of erythrocyte binding protein EBA-175 biologically mimics native protein. |
| Q33818046 | A research agenda for malaria eradication: vaccines |
| Q47995418 | A single amino acid change in the Plasmodium falciparum RH5 (PfRH5) human RBC binding sequence modifies its structure and determines species-specific binding activity |
| Q48030185 | A systematic approach to stabilizing EBA-175 RII-NG for use as a malaria vaccine |
| Q39189734 | ABO blood group phenotypes and Plasmodium falciparum malaria: unlocking a pivotal mechanism. |
| Q47900227 | Absence of antigenic competition in Aotus monkeys immunized with Plasmodium falciparum DNA vaccines delivered as a mixture |
| Q37220749 | Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children |
| Q41813370 | Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1. |
| Q40102134 | Acquisition, maintenance and adaptation of invasion inhibitory antibodies against Plasmodium falciparum invasion ligands involved in immune evasion |
| Q90495391 | Adaptation of Plasmodium falciparum to humans involved the loss of an ape-specific erythrocyte invasion ligand |
| Q36400843 | Adherence of erythrocytes during exflagellation of Plasmodium falciparum microgametes is dependent on erythrocyte surface sialic acid and glycophorins |
| Q33538651 | Adhesive proteins of the malaria parasite |
| Q34145333 | Advances and challenges in malaria vaccine development. |
| Q24806782 | Allelic dimorphism of the erythrocyte binding antigen-175 (eba-175) gene of Plasmodium falciparum and severe malaria: Significant association of the C-segment with fatal outcome in Ghanaian children |
| Q41887879 | Alteration in host cell tropism limits the efficacy of immunization with a surface protein of malaria merozoites |
| Q44460043 | Amino terminal peptides of the ring infected erythrocyte surface antigen of Plasmodium falciparum bind specifically to erythrocytes. |
| Q48352916 | An EBA175 homologue which is transcribed but not translated in erythrocytic stages of Plasmodium falciparum |
| Q30043132 | An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum |
| Q39313046 | An evolutionary approach to identify potentially protective B cell epitopes involved in naturally acquired immunity to malaria and the role of EBA-175 in protection amongst denizens of Bolifamba, Cameroon |
| Q34264741 | An expanding ebl family of Plasmodium falciparum |
| Q47829157 | An unusual tryptophan-rich domain characterizes two secreted antigens of Plasmodium yoelii-infected erythrocytes. |
| Q47853007 | Analysis of Plasmodium falciparum PfEMP-1/var genes suggests that recombination rearranges constrained sequences |
| Q47924332 | Analysis of a Plasmodium falciparum EBA-175 peptide with high binding capacity to erythrocytes and their analogues using 1H NMR. |
| Q47996636 | Analysis of adhesive domains from the A4VAR Plasmodium falciparum erythrocyte membrane protein-1 identifies a CD36 binding domain |
| Q36078771 | Analysis of erythrocyte invasion mechanisms of plasmodium falciparum clinical isolates across 3 malaria-endemic areas in Ghana |
| Q33591313 | Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum |
| Q34537136 | Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum |
| Q47857188 | Analysis of membrane proteins by two-dimensional electrophoresis: comparison of the proteins extracted from normal or Plasmodium falciparum-infected erythrocyte ghosts |
| Q73261388 | Analysis of recombinant merozoite surface protein-1 of Plasmodium falciparum expressed in mammalian cells |
| Q39515040 | Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids |
| Q42051683 | Antibodies raised against receptor-binding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasion |
| Q30845059 | Antibodies targeting the PfRH1 binding domain inhibit invasion of Plasmodium falciparum merozoites |
| Q35569042 | Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria |
| Q27230046 | Antibodies to reticulocyte binding protein-like homologue 4 inhibit invasion of Plasmodium falciparum into human erythrocytes |
| Q34320287 | Antibody response against three Plasmodium falciparum merozoite antigens in Mamuju District, West Sulawesi Province, Indonesia |
| Q38625368 | Antigenic Variation in Plasmodium falciparum |
| Q40918892 | Antigenic variation and immune evasion in Plasmodium falciparum malaria |
| Q24800957 | Antioxidant defense in Plasmodium falciparum--data mining of the transcriptome |
| Q35605940 | Approaches towards the development of a vaccine against tuberculosis: recombinant BCG and DNA vaccine |
| Q37548216 | Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies |
| Q39830868 | Baculovirus-mediated expression of Plasmodium falciparum erythrocyte binding antigen 175 polypeptides and their recognition by human antibodies |
| Q34982236 | Band 3 is a host receptor binding merozoite surface protein 1 during thePlasmodium falciparuminvasion of erythrocytes |
| Q47978995 | Basigin Interacts with Plasmodium vivax Tryptophan-rich Antigen PvTRAg38 as a Second Erythrocyte Receptor to Promote Parasite Growth |
| Q24297064 | Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum |
| Q27974543 | Binding of Plasmodium falciparum Merozoite Surface Proteins DBLMSP and DBLMSP2 to Human Immunoglobulin M Is Conserved among Broadly Diverged Sequence Variants |
| Q27973510 | Biochemical analysis of the Plasmodium falciparum erythrocyte-binding antigen-175 (EBA175)-glycophorin-A interaction: implications for vaccine design |
| Q47880785 | Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax duffy-binding protein |
| Q38936714 | Biological roles of glycans |
| Q40536970 | Blood group antigens defined by the amino acid sequences of red cell surface proteins |
| Q44529839 | Blood groups and structure-activity relations |
| Q36978206 | Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein |
| Q48014614 | CRISPR/Cas9 knockouts reveal genetic interaction between strain-transcendent erythrocyte determinants of Plasmodium falciparum invasion |
| Q52371964 | Calcium-Dependent Protein Kinase 5 Is Required for Release of Egress-Specific Organelles in Plasmodium falciparum. |
| Q41201670 | Cell invasion by the vertebrate stages of Plasmodium |
| Q30043019 | Characterisation of PfRON6, a Plasmodium falciparum rhoptry neck protein with a novel cysteine-rich domain |
| Q73230892 | Characterisation of the binding sites of monoclonal antibodies reacting with the Plasmodium falciparum rhoptry protein RhopH3 |
| Q36283289 | Characterization of Inhibitors and Monoclonal Antibodies That Modulate the Interaction between Plasmodium falciparum Adhesin PfRh4 with Its Erythrocyte Receptor Complement Receptor 1. |
| Q42417080 | Characterization of Plasmodium falciparum integral membrane protein Pf25-IMP and identification of its red blood cell binding sequences inhibiting merozoite invasion in vitro. |
| Q35869245 | Characterization of a Plasmodium falciparum erythrocyte-binding protein paralogous to EBA-175 |
| Q36835223 | Characterizing the genetic diversity of the monkey malaria parasite Plasmodium cynomolgi |
| Q33924720 | Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family |
| Q36243041 | Clinical and molecular aspects of severe malaria |
| Q48042682 | Cloning and sequence analysis of a gene encoding an erythrocyte binding protein from Plasmodium cynomolgi |
| Q47751343 | Close linkage of three merozoite surface protein genes on chromosome 2 of Plasmodium falciparum |
| Q34009561 | Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice. |
| Q48352895 | Comparative analysis of Plasmodium reichenowi and P. falciparum erythrocyte-binding proteins reveals selection to maintain polymorphism in the erythrocyte-binding region of EBA-175. |
| Q37273532 | Comparison of circumsporozoite proteins from avian and mammalian malarias: biological and phylogenetic implications. |
| Q30043671 | Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand |
| Q48023062 | Complex signatures of natural selection at GYPA. |
| Q48036387 | Conservation of structure and function of the erythrocyte-binding domain of Plasmodium falciparum EBA-175. |
| Q41442450 | Cooperativity between Plasmodium falciparum adhesive proteins for invasion into erythrocytes |
| Q40366356 | Correlation between 'H' blood group antigen and Plasmodium falciparum invasion |
| Q34237880 | Critical glycosylated residues in exon three of erythrocyte glycophorin A engage Plasmodium falciparum EBA-175 and define receptor specificity. |
| Q33730132 | Cytoadherence, pathogenesis and the infected red cell surface in Plasmodium falciparum. |
| Q34548667 | Decoding the language of var genes and Plasmodium falciparum sequestration |
| Q38354126 | Definition of structural elements in Plasmodium vivax and P. knowlesi Duffy-binding domains necessary for erythrocyte invasion |
| Q28741027 | Delineation of stage specific expression of Plasmodium falciparum EBA-175 by biologically functional region II monoclonal antibodies |
| Q27670749 | Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC |
| Q47871290 | Disruption of the C-terminal region of EBA-175 in the Dd2/Nm clone of Plasmodium falciparum does not affect erythrocyte invasion |
| Q33788247 | Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands |
| Q33400318 | Distinct roles of Plasmodium rhomboid 1 in parasite development and malaria pathogenesis |
| Q37365601 | Distribution of erythrocyte binding antigen 175 (EBA-175) gene dimorphic alleles in Plasmodium falciparum field isolates from Sudan |
| Q24792618 | Distribution of the two forms of Plasmodium falciparum erythrocyte binding antigen-175 (eba-175) gene in Lao PDR |
| Q64974718 | Divergent roles for the RH5 complex components, CyRPA and RIPR in human-infective malaria parasites. |
| Q33936784 | Domain III of Plasmodium falciparum apical membrane antigen 1 binds to the erythrocyte membrane protein Kx. |
| Q47990409 | Duffy antigen is important for the lethal effect of the lethal strain of Plasmodium yoelii 17XL. |
| Q47882346 | Duffy-null promoter heterozygosity reduces DARC expression and abrogates adhesion of the P. vivax ligand required for blood-stage infection. |
| Q35802357 | Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems |
| Q31017759 | Effects of natural selection and gene conversion on the evolution of human glycophorins coding for MNS blood polymorphisms in malaria-endemic African populations |
| Q90744882 | Epigenetic editing by CRISPR/dCas9 in Plasmodium falciparum |
| Q33293155 | Epigenetic silencing of Plasmodium falciparum genes linked to erythrocyte invasion |
| Q38295399 | Erythrocyte binding antigen (EBA-175) of Plasmodium falciparum: improved genotype determination by nested polymerase chain reaction. |
| Q37181802 | Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion |
| Q38343068 | Erythrocyte binding protein homologues of rodent malaria parasites. |
| Q92993772 | Erythrocyte glycophorins as receptors for Plasmodium merozoites |
| Q34850940 | Erythrocyte invasion phenotypes of Plasmodium falciparum in The Gambia |
| Q45292197 | Erythrocyte invasion profiles are associated with a common invasion ligand polymorphism in Senegalese isolates of Plasmodium falciparum |
| Q35150324 | Erythrocyte polymorphisms and malaria parasite invasion in Papua New Guinea |
| Q47889644 | Erythrocyte-binding activity of Plasmodium yoelii apical membrane antigen-1 expressed on the surface of transfected COS-7 cells |
| Q34960640 | Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways |
| Q37202344 | Erythrocyte-binding antigens of Plasmodium falciparum are targets of human inhibitory antibodies and function to evade naturally acquired immunity |
| Q42041326 | Erythrocytic stage-dependent regulation of oligomerization of Plasmodium ribosomal protein P2. |
| Q45021646 | Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein |
| Q34033392 | Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites |
| Q38897395 | Evidence for diversifying selection on erythrocyte-binding antigens of Plasmodium falciparum and P. vivax |
| Q34937705 | Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine |
| Q48003263 | Evidence supporting the hypothesis that specifically modifying a malaria peptide to fit into HLA-DRbeta1*03 molecules induces antibody production and protection |
| Q33943886 | Evolution of human-chimpanzee differences in malaria susceptibility: relationship to human genetic loss of N-glycolylneuraminic acid |
| Q33687866 | Evolutionary considerations in relating oligosaccharide diversity to biological function |
| Q46870408 | Expression and purification of a Plasmodium vivax antigen - PvTARAg55 tryptophan- and alanine-rich antigen and its immunological responses in human subjects |
| Q35551014 | Expression and serologic activity of a soluble recombinant Plasmodium vivax Duffy binding protein. |
| Q39299603 | Expression of Plasmodium falciparum genes involved in erythrocyte invasion varies among isolates cultured directly from patients |
| Q54101277 | Expression of the membrane protein glycophorin A as a fusion with the antibiotic resistance protein neomycin phosphotransferase II. |
| Q35701584 | Expression, Purification, and Biological Characterization of Babesia microti Apical Membrane Antigen 1. |
| Q64093393 | Few Plasmodium falciparum merozoite ligand and erythrocyte receptor pairs show evidence of balancing selection |
| Q33505350 | Fine mapping of Plasmodium falciparum ribosomal phosphoprotein PfP0 revealed sequences with highly specific binding activity to human red blood cells |
| Q37642585 | From evolutionary genetics to human immunology: how selection shapes host defence genes |
| Q35212980 | Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development |
| Q36059825 | Functional analysis of erythrocyte determinants of Plasmodium infection |
| Q33606511 | Functional aspects of red cell antigens |
| Q39870390 | Functional diversification between two related Plasmodium falciparum merozoite invasion ligands is determined by changes in the cytoplasmic domain |
| Q36631336 | Gene Models, Expression Repertoire, and Immune Response of Plasmodium vivax Reticulocyte Binding Proteins |
| Q39311679 | Genes coding for tryptophan-rich proteins are transcribed throughout the asexual cycle of Plasmodium falciparum |
| Q58394964 | Genetic Mapping of Virulence in Rodent Malarias |
| Q43144354 | Genetic analysis of the cytoplasmic domain of the PfRh2b merozoite invasion protein of Plasmodium falciparum |
| Q36142562 | Genetic diversity of Plasmodium falciparum isolates from Baka Pygmies and their Bantu neighbours in the north of Gabon |
| Q35908103 | Genetic evidence for contribution of human dispersal to the genetic diversity of EBA-175 in Plasmodium falciparum |
| Q48031812 | Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates |
| Q48051980 | Genetic restriction in two conserved regions of Plasmodium falciparum EBA-1751t |
| Q93122728 | Getting in: The structural biology of malaria invasion |
| Q38299754 | Glycophorin A-knockout mice, which lost sialoglycoproteins from the red blood cell membrane, are resistant to lethal infection of Babesia rodhaini |
| Q37146848 | Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1 |
| Q36938795 | Heterologous expression of plasmodial proteins for structural studies and functional annotation |
| Q27230084 | Host cell invasion by malaria parasites |
| Q35547427 | How many pathways for invasion of the red blood cell by the malaria parasite? |
| Q27972783 | Human erythrocyte band 3 functions as a receptor for the sialic acid-independent invasion of Plasmodium falciparum. Role of the RhopH3-MSP1 complex |
| Q61716150 | Human erythrocyte band 3 is a host receptor for glutamic acid-rich protein |
| Q90042156 | Human genetics and malaria resistance |
| Q27230016 | Identification and characterization of a novel Plasmodium falciparum adhesin involved in erythrocyte invasion |
| Q33890328 | Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria |
| Q41821299 | Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies |
| Q34138300 | Identification of a specific region of Plasmodium falciparum EBL-1 that binds to host receptor glycophorin B and inhibits merozoite invasion in human red blood cells |
| Q33761565 | Identification of an erythrocyte binding peptide from the erythrocyte binding antigen, EBA-175, which blocks parasite multiplication and induces peptide-blocking antibodies |
| Q34034224 | Identification, cloning, expression, and characterization of the gene for Plasmodium knowlesi surface protein containing an altered thrombospondin repeat domain |
| Q37233262 | Identifying novel Plasmodium falciparum erythrocyte invasion receptors using systematic extracellular protein interaction screens |
| Q34537144 | Imbalanced distribution of Plasmodium falciparum EBA-175 genotypes related to clinical status in children from Bakoumba, Gabon |
| Q44689320 | Immunogenicity and protectivity of Plasmodium falciparum EBA-175 peptide and its analog is associated with alpha-helical region shortening and displacement. |
| Q48036529 | Immunogenicity of a recombinant malaria vaccine based on receptor binding domain of Plasmodium falciparum EBA-175. |
| Q35330733 | Impact of the RTS,S malaria vaccine candidate on naturally acquired antibody responses to multiple asexual blood stage antigens |
| Q35022782 | In Vitro Genetic Analysis of an Erythrocyte Determinant of Malaria Infection |
| Q34658695 | In silico studies on DARC. |
| Q39571722 | In vivo binding of immunoglobulin M to the surfaces of Babesia bigemina-infected erythrocytes. |
| Q27973516 | Independent translocation of two micronemal proteins in developing Plasmodium falciparum merozoites |
| Q37124750 | Inhibitory humoral responses to the Plasmodium falciparum vaccine candidate EBA-175 are independent of the erythrocyte invasion pathway |
| Q37643881 | Inside scoop on outside proteins |
| Q27670958 | Insights into Duffy Binding-like Domains through the Crystal Structure and Function of the Merozoite Surface Protein MSPDBL2 from Plasmodium falciparum |
| Q30380793 | Insights into the Immunological Properties of Intrinsically Disordered Malaria Proteins Using Proteome Scale Predictions. |
| Q33236499 | Interaction between the membrane protein of a pathogen and insect microfilament complex determines insect-vector specificity |
| Q33643639 | Intracellular life |
| Q33538664 | Intracellular trafficking in Plasmodium-infected erythrocytes |
| Q30043432 | Intramembrane proteolysis mediates shedding of a key adhesin during erythrocyte invasion by the malaria parasite |
| Q21559521 | Invasion by P. falciparum merozoites suggests a hierarchy of molecular interactions |
| Q36881595 | Invasion of host cells by malaria parasites: a tale of two protein families |
| Q42432566 | Invasion pathways and malaria severity in Kenyan Plasmodium falciparum clinical isolates |
| Q37524172 | Invasion profiles of Brazilian field isolates of Plasmodium falciparum: phenotypic and genotypic analyses |
| Q34103150 | Isolation of multiple sequences from the Plasmodium falciparum genome that encode conserved domains homologous to those in erythrocyte-binding proteins |
| Q36447783 | Lipid rafts and malaria parasite infection of erythrocytes |
| Q33807008 | Low-high season variation in Plasmodium falciparum erythrocyte binding antigen 175 (eba-175) allelic forms in malaria endemic area of Burkina Faso |
| Q37728315 | Malaria adhesins: structure and function |
| Q35887367 | Malaria invasion ligand RH5 and its prime candidacy in blood-stage malaria vaccine design |
| Q38332235 | Malaria merozoite surface protein antisense oligodeoxynucleotides lack antisense activity but function as polyanions to inhibit red cell invasion |
| Q37445490 | Malaria parasite proteins that remodel the host erythrocyte |
| Q36707751 | Mapping regions containing binding residues within functional domains of Plasmodium vivax and Plasmodium knowlesi erythrocyte-binding proteins. |
| Q35550197 | Measurement of antibody levels against region II of the erythrocyte-binding antigen 175 of Plasmodium falciparum in an area of malaria holoendemicity in western Kenya |
| Q27230075 | Merozoite surface protein 1 recognition of host glycophorin A mediates malaria parasite invasion of red blood cells |
| Q26772878 | Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria |
| Q47843233 | Model multiple antigenic and homopolymeric peptides from non-repetitive sequences of malaria merozoite proteins elicit biologically irrelevant antibodies |
| Q40107155 | Molecular Cloning and Characterization of Babesia orientalis Rhoptry Neck 2 BoRON2 Protein. |
| Q42432429 | Molecular analysis of erythrocyte invasion in Plasmodium falciparum isolates from Senegal |
| Q24550715 | Molecular aspects of severe malaria |
| Q41739876 | Molecular basis for evasion of host immunity and pathogenesis in malaria |
| Q37347698 | Molecular basis of binding of the Plasmodium falciparum receptor BAEBL to erythrocyte receptor glycophorin C. |
| Q44161286 | Multi-gene vaccination against malaria: A multistage, multi-immune response approach |
| Q35190960 | Multimeric assembly of host-pathogen adhesion complexes involved in apicomplexan invasion |
| Q37775257 | Multiple interests in structural models of DARC transmembrane protein. |
| Q34548865 | Natural variation within the principal adhesion domain of the Plasmodium vivax duffy binding protein |
| Q34004570 | Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein. |
| Q39249136 | Neurobiology of cerebral malaria and African sleeping sickness |
| Q35216634 | New antigens for a multicomponent blood-stage malaria vaccine |
| Q27972792 | Novel putative glycosylphosphatidylinositol-anchored micronemal antigen of Plasmodium falciparum that binds to erythrocytes |
| Q39444427 | Pathogen-driven selection in the human genome |
| Q63860524 | PfMSA180 is a novel Plasmodium falciparum vaccine antigen that interacts with human erythrocyte integrin associated protein (CD47). |
| Q30049204 | PfRH5: a novel reticulocyte-binding family homolog of plasmodium falciparum that binds to the erythrocyte, and an investigation of its receptor |
| Q35557657 | Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175. |
| Q30042170 | Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes |
| Q33716582 | Placental malaria diminishes development of antibody responses to Plasmodium falciparum epitopes in infants residing in an area of western Kenya where P. falciparum is endemic |
| Q33581871 | Plasmodium falciparum BAEBL binds to heparan sulfate proteoglycans on the human erythrocyte surface |
| Q30045308 | Plasmodium falciparum MAEBL is a unique member of the ebl family |
| Q34163026 | Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations |
| Q30043551 | Plasmodium falciparum erythrocyte-binding antigen 175 triggers a biophysical change in the red blood cell that facilitates invasion |
| Q34002398 | Plasmodium falciparum field isolates commonly use erythrocyte invasion pathways that are independent of sialic acid residues of glycophorin A |
| Q34464648 | Plasmodium falciparum field isolates from South America use an atypical red blood cell invasion pathway associated with invasion ligand polymorphisms |
| Q34007632 | Plasmodium falciparum homologue of the genes for Plasmodium vivax and Plasmodium yoelii adhesive proteins, which is transcribed but not translated. |
| Q34945556 | Plasmodium falciparum is able to invade erythrocytes through a trypsin-resistant pathway independent of glycophorin B |
| Q30042563 | Plasmodium falciparum ligand binding to erythrocytes induce alterations in deformability essential for invasion |
| Q33840763 | Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion |
| Q30425504 | Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes |
| Q37188081 | Plasmodium in the postgenomic era: new insights into the molecular cell biology of malaria parasites. |
| Q40441210 | Plasmodium vivax:a glimpse into the unique and shared biology of the merozoite |
| Q31955934 | Plasmodium yoelii YM MAEBL protein is coexpressed and colocalizes with rhoptry proteins. |
| Q36371888 | Polymorphism in a Plasmodium falciparum erythrocyte-binding ligand changes its receptor specificity |
| Q36602637 | Polymorphism in the Plasmodium falciparum erythrocyte-binding ligand JESEBL/EBA-181 alters its receptor specificity |
| Q38909388 | Population genetic analysis of the Plasmodium falciparum erythrocyte binding antigen-175 (eba-175) gene |
| Q40612771 | Positive selection underlies the species-specific binding of Plasmodium falciparum RH5 to human basigin. |
| Q35464579 | Primary structure of the variable region of monoclonal antibody 2B10, capable of inducing anti-idiotypic antibodies that recognize the C-terminal region of MSA-1 of Plasmodium falciparum. |
| Q35147457 | Quantification of Plasmodium-host protein interactions on intact, unmodified erythrocytes by back-scattering interferometry |
| Q33898677 | Rapid identification of genes controlling virulence and immunity in malaria parasites. |
| Q37283037 | Recent highlights in antimalarial drug resistance and chemotherapy research |
| Q53363432 | Recombinant blood group antigens are useful for studying the fine specificity of antibodies against glycophorin A encoded antigens. |
| Q99557592 | Red blood cell tension protects against severe malaria in the Dantu blood group |
| Q38696399 | Red cell receptors as access points for malaria infection |
| Q40859526 | Research toward vaccines against malaria |
| Q34739631 | Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites |
| Q38086308 | Reticulocytes: Plasmodium vivax target cells. |
| Q56768068 | Retracted article: Alternative pathways of erythrocyte invasion, parasite multiplication potential and severity of the clinical episode of P. falciparum malaria in the Peruvian Amazon |
| Q92910897 | Rosetting revisited: a critical look at the evidence for host erythrocyte receptors in Plasmodium falciparum rosetting |
| Q37265801 | Safety and immunogenicity of EBA-175 RII-NG Malaria vaccine administered intramuscularly in semi-immune adults: A Phase 1, Double-blinded placebo controlled dosage escalation study |
| Q34189972 | Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemic |
| Q36574313 | Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. |
| Q60301624 | Shed EBA-175 mediates red blood cell clustering that enhances malaria parasite growth and enables immune evasion |
| Q43545546 | Sialic acid-dependent binding of baculovirus-expressed recombinant antigens from Plasmodium falciparum EBA-175 to Glycophorin A. |
| Q35102544 | Small molecule targeting malaria merozoite surface protein-1 (MSP-1) prevents host invasion of divergent plasmodial species. |
| Q43058980 | Specific erythrocyte binding capacity and biological activity of Plasmodium falciparum erythrocyte binding ligand 1 (EBL-1)-derived peptides |
| Q71011177 | Stabilization of the T1 fragment of glycophorin A(N) through interactions with N-and O-linked glycans |
| Q27678372 | Structural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target Plasmodium falciparum EBA-175 |
| Q92325722 | Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP |
| Q48013061 | Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum |
| Q55429433 | Structural patterns of selection and diversity for Plasmodium vivax antigens DBP and AMA1. |
| Q34515219 | Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria |
| Q35483364 | Sulfated polyanions inhibit invasion of erythrocytes by plasmodial merozoites and cytoadherence of endothelial cells to parasitized erythrocytes |
| Q29618991 | Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes |
| Q44217572 | Synthesis of C-glycosyl compounds of N-acetylneuraminic acid from D-gluconolactone |
| Q48004710 | Targeted deletion of Plasmodium knowlesi Duffy binding protein confirms its role in junction formation during invasion |
| Q35162176 | Targeted disruption of an erythrocyte binding antigen in Plasmodium falciparum is associated with a switch toward a sialic acid-independent pathway of invasion |
| Q47389892 | Targeting a DBL3gamma domain of the Plasmodium falciparum erythrocyte membrane protein 1 to the surface of Saccharomyces cerevisiae. |
| Q34131196 | Targeting sialic acid dependent and independent pathways of invasion in Plasmodium falciparum |
| Q36405378 | Targeting wild-type Erythrocyte receptors for Plasmodium falciparum and vivax Merozoites by Zinc Finger Nucleases In- silico: Towards a Genetic Vaccine against Malaria |
| Q36891440 | The M18 aspartyl aminopeptidase of Plasmodium falciparum binds to human erythrocyte spectrin in vitro |
| Q58618787 | The Malaria-Protective Human Glycophorin Structural Variant DUP4 Shows Somatic Mosaicism and Association with Hemoglobin Levels |
| Q34428497 | The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria. |
| Q28656467 | The SLC4A1 gene is under differential selective pressure in primates infected by Plasmodium falciparum and related parasites |
| Q36339851 | The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1. |
| Q34094870 | The apical organelles of malaria merozoites: host cell selection, invasion, host immunity and immune evasion. |
| Q35542746 | The baculovirus-expressed binding region of Plasmodium falciparum EBA-140 ligand and its glycophorin C binding specificity |
| Q21032502 | The cellular and molecular basis for malaria parasite invasion of the human red blood cell |
| Q50523946 | The cysteine-rich regions of Plasmodium falciparum RON2 bind with host erythrocyte and AMA1 during merozoite invasion. |
| Q36323222 | The cytoplasmic domain of the Plasmodium falciparum ligand EBA-175 is essential for invasion but not protein trafficking |
| Q36367429 | The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes |
| Q34606720 | The epitope of monoclonal antibodies blocking erythrocyte invasion by Plasmodium falciparum map to the dimerization and receptor glycan binding sites of EBA-175. |
| Q37471465 | The future for blood-stage vaccines against malaria |
| Q27230097 | The glycophorin C N-linked glycan is a critical component of the ligand for the Plasmodium falciparum erythrocyte receptor BAEBL. |
| Q38909394 | The major allelic dimorphisms in four Plasmodium falciparum merozoite proteins are not associated with alternative pathways of erythrocyte invasion |
| Q34470655 | The malaria-infected red blood cell: structural and functional changes |
| Q84511507 | The molecular genetics of blood group polymorphism |
| Q29615020 | The pathogenic basis of malaria |
| Q26862567 | The role of PfEMP1 adhesion domain classification in Plasmodium falciparum pathogenesis research |
| Q35080827 | Tracking Glideosome-associated protein 50 reveals the development and organization of the inner membrane complex of Plasmodium falciparum. |
| Q33857816 | Transcripts of developmentally regulated Plasmodium falciparum genes quantified by real-time RT-PCR. |
| Q47208042 | Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax. |
| Q27680572 | Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor |
| Q34988452 | Vaccination with conserved regions of erythrocyte-binding antigens induces neutralizing antibodies against multiple strains of Plasmodium falciparum |
| Q35609283 | Variation in Plasmodium falciparum erythrocyte invasion phenotypes and merozoite ligand gene expression across different populations in areas of malaria endemicity |
| Q34131763 | Variation in the expression of a Plasmodium falciparum protein family implicated in erythrocyte invasion |
| Q36227228 | Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies |
| Q36678022 | Various PfRH5 polymorphisms can support Plasmodium falciparum invasion into the erythrocytes of owl monkeys and rats |
| Q44168891 | Wheat germ cell-free technology for accelerating the malaria vaccine research |
| Q37426820 | World Malaria Day 2009: what malaria knows about the immune system that immunologists still do not. |
| Q52200434 | [Malaria--biological aspects of an infectious disease of importance to humans]. |
| Q56564080 | erythrocyte binding antigen-175 | described by source | P1343 |
Search more.